https://www.macrotrends.net/stocks/charts/PRQR/proqr-therapeutics/financial-statements
ProQR Therapeutics Financial Statements 2013-2026 | PRQR | MacroTrends
Ten years of annual and quarterly financial statements and annual report data for ProQR Therapeutics (PRQR). Income statements, balance sheets, cash flow...
financial statementsproqrtherapeutics20132026
https://www.biospace.com/proqr-therapeutics-b-v-announces-results-for-the-first-quarter-of-2015
ProQR Therapeutics B.V. Announces Results For The First Quarter Of 2015 - BioSpace
https://www.globenewswire.com/news-release/2018/05/09/1499294/0/en/ProQR-Announces-Results-for-the-First-Quarter-of-2018.html
ProQR Announces Results for the First Quarter of 2018
Key updates Eight out of twelve patients have been enrolled in a Phase 1/2 clinical trial of QR-110 in adults and children with LCA 10. Interim data...
results forthe firstproqrannouncesquarter
https://finviz.com/quote?t=PRQR&ty=fc&ta=1&p=d
PRQR - ProQR Therapeutics N.V Forecast, Target Price
PRQR - ProQR Therapeutics N.V - Stock screener for investors and traders, financial visualizations.
n vprqrproqrtherapeuticsforecast
https://www.prnewswire.com/news-releases/the-usher-syndrome-coalition-announces-partnership-with-proqr-to-support-clinical-trial-enrollment-for-a-potential-therapy-for-ush2a-mediated-retinitis-pigmentosa-301470693.html
The Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment...
/PRNewswire/ -- For more than ten years, the Usher Syndrome Coalition has been working to build its international "USH Trust" registry in anticipation of the...
https://www.biospace.com/press-releases/proqr-highlights-upcoming-presentation-at-20th-annual-meeting-of-the-oligonucleotide-therapeutics-society
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics...
https://www.biospace.com/press-releases/proqr-announces-upcoming-presentation-at-rna-editing-summit
ProQR Announces Upcoming Presentation at RNA Editing Summit - BioSpace
rna editingproqrannouncesupcomingpresentation
https://www.globenewswire.com/fr/news-release/2026/02/09/3234489/33039/en/ProQR-Announces-Planned-Changes-to-Board-Composition.html
ProQR Announces Planned Changes to Board Composition
planned changesproqrannouncesboardcomposition
https://www.biospace.com/proqr-therapeutics-b-v-announces-results-for-the-fourth-quarter-and-full-year-2014
ProQR Therapeutics B.V. Announces Results For The Fourth Quarter And Full Year 2014 - BioSpace
https://www.ig.com/en-ch/shares/markets-shares/proqr-therapeutics-nv
Trade ProQR Therapeutics NV Shares | Live ProQR Therapeutics NV Share Price | IG Switzerland | IG...
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of... [EN-CH]
live share pricetradeproqrtherapeuticsnv
https://www.globenewswire.com/de/news-release/2024/01/19/2812237/33039/en/ProQR-Highlights-New-Platform-Data-from-Presentation-on-Axiomer-RNA-Editing-Technology-at-Deaminet-2024.html
ProQR Highlights New Platform Data from Presentation on
Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human primates (NHPs) and miceFunctional...
new platformdata fromproqrhighlightspresentation
https://www.ig.com/it-ch/azioni/mercati-azioni/proqr-therapeutics-nv
Trading Azioni ProQR Therapeutics NV | Prezzo Azioni ProQR Therapeutics NV | IG Svizzera | IG Bank...
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of... [IT-CH]
trading azioniproqrtherapeuticsnvprezzo
https://www.proqr.com/
ProQR Therapeutics - Creating RNA therapies for patients in need
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
rna therapiesfor patientsproqrtherapeuticscreating
https://www.proqr.com.au/
HOME | proqr
proqr
https://www.sec.gov/Archives/edgar/data/1612940/000155837025002851/tmb-20241231x20f.htm
ProQR Therapeutics N.V._December 31, 2024
n vdecember 31proqrtherapeutics2024
https://www.biospace.com/press-releases/proqr-announces-webcast-of-presentation-at-the-2025-citizens-life-sciences-conference
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference - BioSpace
https://www.ig.com/fr-ch/actions/marches-actions/proqr-therapeutics-nv
Action ProQR Therapeutics NV | Cours ProQR Therapeutics NV | ProQR Therapeutics NV | IG Suisse | IG...
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of... [FR-CH]
actionproqrtherapeuticsnvcours
https://www.biospace.com/proqr-therapeutics-b-v-remembers-co-founder-b-henri-termeer-b-after-his-unexpected-passing
ProQR Therapeutics B.V. Remembers Co-Founder Henri Termeer After His Unexpected Passing - BioSpace
https://www.epo.org/fr/boards-of-appeal/decisions/t231121eu1
T 1121/23 (Targeted RNA Editing/PROQR THERAPEUTICS II) du 30.09.2025